Preliminary analyses in different cognitive groups demonstrated that the reduced CSF complement peptides C1q, C2, C5, and CFB were associated with longitudinal brain atrophy (i.e., ventricles, whole brain, middle temporal lobe, or fusiform gyrus) and cognitive decline in MCI participants. This evidence concerns the gene C2 and Mental deterioration.